Cargando…

Multifaceted Influence of Histone Deacetylases on DNA Damage Repair: Implications for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers and a leading cause of cancer-related mortality worldwide, but its pathogenesis remains largely unknown. Nevertheless, genomic instability has been recognized as one of the facilitating characteristics of cancer hallmarks t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Gan, Yang, Ruizhe, Qiu, Jianguo, Xia, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647118/ https://www.ncbi.nlm.nih.gov/pubmed/36406320 http://dx.doi.org/10.14218/JCTH.2022.00079

Ejemplares similares

The multifaceted influence of histone deacetylases on DNA damage signalling and DNA repair
por: Roos, Wynand Paul, et al.
Publicado: (2016)

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair
por: Groselj, B, et al.
Publicado: (2013)

Histone deacetylase inhibitors mediate DNA damage repair in ameliorating hemorrhagic cystitis
por: Haldar, Subhash, et al.
Publicado: (2016)

Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer
por: Alzoubi, Samer, et al.
Publicado: (2016)

The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer
por: Knoche, Shelby M., et al.
Publicado: (2022)

Histone Acetyltransferases and Deacetylases Are Required for Virulence, Conidiation, DNA Damage Repair, and Multiple Stresses Resistance of Alternaria alternata
por: Ma, Haijie, et al.
Publicado: (2021)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
por: Freese, Kim, et al.
Publicado: (2019)

Histone Deacetylase Inhibitors, Intrinsic and Extrinsic Apoptotic Pathways, and Epigenetic Alterations of Histone Deacetylases (HDACs) in Hepatocellular Carcinoma
por: Sanaei, Masumeh, et al.
Publicado: (2021)

Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response
por: Kao, Gary D., et al.
Publicado: (2003)

Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes
por: Kiweler, Nicole, et al.
Publicado: (2020)

DNA and histone deacetylases as targets for neuroblastoma treatment
por: Stiborová, Marie, et al.
Publicado: (2010)

Deacetylase undoes DNA damage
por: LeBrasseur, Nicole
Publicado: (2003)

Histone deacetylase inhibitors: clinical implications for hematological malignancies
por: Tambaro, Francesco Paolo, et al.
Publicado: (2010)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Natural Products Impacting DNA Methyltransferases and Histone Deacetylases
por: Akone, Sergi Herve, et al.
Publicado: (2020)

Generation of Reactive Oxygen Species during Apoptosis Induced by DNA-Damaging Agents and/or Histone Deacetylase Inhibitors
por: Brodská, Barbora, et al.
Publicado: (2011)

PAICS contributes to gastric carcinogenesis and participates in DNA damage response by interacting with histone deacetylase 1/2
por: Huang, Nan, et al.
Publicado: (2020)

Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells
por: Yang, Wen-Bin, et al.
Publicado: (2021)

Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies
por: Sandonà, Martina, et al.
Publicado: (2023)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Inheritance of paternal DNA damage by histone-mediated repair restriction
por: Wang, Siyao, et al.
Publicado: (2022)

Psychostimulants and opioids differentially influence the epigenetic modification of histone acetyltransferase and histone deacetylase in astrocytes
por: Doke, Mayur, et al.
Publicado: (2021)

Subcellular Localization of Class I Histone Deacetylases in the Developing Xenopus tectum
por: Guo, Xia, et al.
Publicado: (2016)

Editorial: Grappling with the Multifaceted World of the DNA Damage Response
por: Porro, Antonio
Publicado: (2016)

Editorial: Epigenetic Therapy With Histone Deacetylase Inhibitors: Implications for Cancer Treatment
por: Sousa, Angela, et al.
Publicado: (2021)

Sex Differences in Psychostimulant Abuse: Implications for Estrogen Receptors and Histone Deacetylases
por: Torres, Oscar V.
Publicado: (2022)

Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism
por: Molinari, Susanna, et al.
Publicado: (2023)

The deacetylase SIRT6 promotes the repair of UV-induced DNA damage by targeting DDB2
por: Geng, Anke, et al.
Publicado: (2020)

Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
por: Garmpis, Nikolaos, et al.
Publicado: (2021)

Chemical Phylogenetics of Histone Deacetylases
por: Bradner, James E., et al.
Publicado: (2010)

Histone deacetylases in viral infections
por: Herbein, Georges, et al.
Publicado: (2010)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Histone deacetylase signaling in cardioprotection
por: Lehmann, Lorenz H., et al.
Publicado: (2013)

Histone deacetylase 6 in cancer
por: Li, Ting, et al.
Publicado: (2018)

Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
por: Yan, Wensheng, et al.
Publicado: (2012)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer
por: Xu, Xiaoxin S, et al.
Publicado: (2011)

Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage
por: Fukuda, Takayo, et al.
Publicado: (2015)

The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells
por: Cerna, Tereza, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_04bl3p8lam5vkebvm2a7mrjn06